investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Expanded Phase II Trial of Carraguard for Prevention of HPV Infection
Mark H. Einstein
0 Collaborator(s)
Funding source
National Institutes of Health (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Mark H. Einstein
Albert Einstein College of Medicine
Bronx, United States
Related projects
Michael Frumovitz
A Phase III Randomized Study of Pretherapeutic Para-aortic Lymphadenectomy in Women With Locally Advanced Cervical Cancer Dispositioned to Definitive Chemoradiotherapy
Cervix uteri
Radiation Oncology
Global Noncommunicable Diseases Intiatives
NVS
Cervix uteri
Corey Casper
Biologic Determinants of the Natural History of AIDS-Defining Cancers in Uganda
Cervix uteri
Pediatric oncology or childhood cancer
Patricia Jean Johnson
Trichomonas vaginalis exosomes: Mediators of host:pathogen interactions
Cervix uteri
Pathology
Frederick Appelbaum
Cancer Center Support Grant (Comprehensive)
Cervix uteri
Global Noncommunicable Diseases Intiatives
Cryotherapy market dynamics: Increasing access to treatment of HPV-related disease - 3
Cervix uteri
Global Noncommunicable Diseases Intiatives
Cervical Cancer Vacination Programme - Train the Trainers
Cervix uteri
Global Noncommunicable Diseases Intiatives
Establishing routine use of new technologies for detecting HPV and preventing cervical cancer in low-resource settings - 3
Cervix uteri
Kathryn Anastos
Developing Rwandan Research Capacity in Cervical Cancer and Other Aids Malignancies
Cervix uteri